Middle Eastern countries, disregarding the influence of the U.S., which thinks little of international order, are eyeing a move to a framework to independently ensure their own national security.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.